Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
40.61
USD
|
+2.06%
|
|
+5.59%
|
-2.71%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,577
|
14,020
|
13,748
|
8,147
|
7,185
|
6,978
|
-
|
-
|
Enterprise Value (EV)
1 |
9,406
|
13,751
|
13,424
|
7,965
|
6,983
|
6,573
|
6,397
|
6,171
|
P/E ratio
|
48.3
x
|
80.3
x
|
49.8
x
|
38.3
x
|
64.2
x
|
54.7
x
|
34.1
x
|
25
x
|
Yield
|
0.37%
|
0.28%
|
0.32%
|
0.56%
|
0.69%
|
0.75%
|
0.79%
|
0.84%
|
Capitalization / Revenue
|
13.2
x
|
17.3
x
|
13.3
x
|
8.1
x
|
8.58
x
|
7.48
x
|
6.52
x
|
5.77
x
|
EV / Revenue
|
13
x
|
17
x
|
12.9
x
|
7.92
x
|
8.34
x
|
7.05
x
|
5.98
x
|
5.1
x
|
EV / EBITDA
|
56.2
x
|
56.7
x
|
40
x
|
27.6
x
|
45.2
x
|
38.4
x
|
24.5
x
|
18.2
x
|
EV / FCF
|
40.6
x
|
60
x
|
45
x
|
35.6
x
|
77.7
x
|
34.2
x
|
28.3
x
|
21.3
x
|
FCF Yield
|
2.46%
|
1.67%
|
2.22%
|
2.81%
|
1.29%
|
2.92%
|
3.53%
|
4.7%
|
Price to Book
|
7.13
x
|
11.2
x
|
9.78
x
|
5.73
x
|
4.76
x
|
4.33
x
|
3.89
x
|
3.49
x
|
Nbr of stocks (in thousands)
|
170,897
|
174,633
|
176,799
|
172,930
|
172,142
|
171,821
|
-
|
-
|
Reference price
2 |
56.04
|
80.28
|
77.76
|
47.11
|
41.74
|
40.61
|
40.61
|
40.61
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
725.6
|
811
|
1,037
|
1,006
|
837.5
|
932.6
|
1,070
|
1,210
|
EBITDA
1 |
167.5
|
242.4
|
335.4
|
288.3
|
154.5
|
171.3
|
260.7
|
339.9
|
EBIT
1 |
142.6
|
170.5
|
315.1
|
268.7
|
137.3
|
145.2
|
232.3
|
310
|
Operating Margin
|
19.65%
|
21.03%
|
30.38%
|
26.7%
|
16.39%
|
15.57%
|
21.71%
|
25.62%
|
Earnings before Tax (EBT)
1 |
163
|
186.9
|
318.9
|
250.7
|
135.3
|
151.3
|
240.7
|
329.7
|
Net income
1 |
203.9
|
176.2
|
279.9
|
215.5
|
113.2
|
127.7
|
203.9
|
283.1
|
Net margin
|
28.1%
|
21.72%
|
26.99%
|
21.42%
|
13.52%
|
13.69%
|
19.06%
|
23.4%
|
EPS
2 |
1.160
|
1.000
|
1.560
|
1.230
|
0.6500
|
0.7418
|
1.190
|
1.625
|
Free Cash Flow
1 |
231.5
|
229.1
|
298.6
|
223.7
|
89.84
|
192
|
225.8
|
289.9
|
FCF margin
|
31.9%
|
28.25%
|
28.79%
|
22.24%
|
10.73%
|
20.59%
|
21.11%
|
23.96%
|
FCF Conversion (EBITDA)
|
138.2%
|
94.5%
|
89.04%
|
77.61%
|
58.13%
|
112.09%
|
86.63%
|
85.29%
|
FCF Conversion (Net income)
|
113.55%
|
130.03%
|
106.69%
|
103.81%
|
79.34%
|
150.39%
|
110.73%
|
102.38%
|
Dividend per Share
2 |
0.2050
|
0.2250
|
0.2450
|
0.2650
|
0.2860
|
0.3057
|
0.3219
|
0.3426
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
284.8
|
244.1
|
282.4
|
274.6
|
209.6
|
239.4
|
201.1
|
242.5
|
197.2
|
196.7
|
200.4
|
234.5
|
249
|
243.3
|
229.9
|
EBITDA
1 |
92.6
|
61.39
|
91.68
|
87.36
|
47.78
|
61.46
|
27.09
|
67.61
|
34.18
|
24.85
|
17.83
|
42.07
|
55.77
|
51.67
|
35.64
|
EBIT
1 |
87.55
|
56.52
|
86.73
|
82.54
|
42.91
|
56.48
|
22.16
|
62.68
|
29.06
|
20.14
|
11.86
|
37.74
|
49.87
|
44.61
|
29.95
|
Operating Margin
|
30.73%
|
23.16%
|
30.71%
|
30.06%
|
20.47%
|
23.59%
|
11.02%
|
25.84%
|
14.73%
|
10.24%
|
5.92%
|
16.1%
|
20.03%
|
18.34%
|
13.03%
|
Earnings before Tax (EBT)
1 |
88.58
|
57.95
|
87.7
|
64.42
|
39.34
|
59.23
|
26.22
|
67.78
|
27
|
14.35
|
12.91
|
39.83
|
51.59
|
45.95
|
30.87
|
Net income
1 |
78.9
|
53.54
|
67.33
|
58.9
|
33.98
|
55.31
|
25.62
|
57.47
|
18.92
|
11.23
|
10.97
|
33.73
|
43.27
|
38.72
|
27.22
|
Net margin
|
27.7%
|
21.93%
|
23.84%
|
21.45%
|
16.21%
|
23.1%
|
12.74%
|
23.7%
|
9.59%
|
5.71%
|
5.47%
|
14.39%
|
17.38%
|
15.91%
|
11.84%
|
EPS
2 |
0.4400
|
0.3000
|
0.3800
|
0.3400
|
0.1900
|
0.3200
|
0.1500
|
0.3300
|
0.1100
|
0.0700
|
0.0641
|
0.1973
|
0.2511
|
0.2252
|
0.1560
|
Dividend per Share
2 |
0.0600
|
0.0600
|
0.0650
|
0.0650
|
0.0650
|
0.0700
|
0.0700
|
0.0700
|
0.0700
|
0.0750
|
0.0750
|
0.0750
|
0.0754
|
0.0784
|
0.0761
|
Announcement Date
|
11/4/21
|
2/17/22
|
5/5/22
|
8/2/22
|
11/3/22
|
2/16/23
|
5/4/23
|
8/3/23
|
10/31/23
|
2/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
171
|
269
|
324
|
181
|
203
|
404
|
580
|
806
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
231
|
229
|
299
|
224
|
89.8
|
192
|
226
|
290
|
ROE (net income / shareholders' equity)
|
16.4%
|
13.5%
|
20.8%
|
15%
|
8.66%
|
8.64%
|
12.6%
|
14.6%
|
ROA (Net income/ Total Assets)
|
8.6%
|
9.56%
|
14.7%
|
10.9%
|
-
|
5.8%
|
7.3%
|
-
|
Assets
1 |
2,371
|
1,843
|
1,902
|
1,981
|
-
|
2,201
|
2,794
|
-
|
Book Value Per Share
2 |
7.860
|
7.180
|
7.950
|
8.230
|
8.770
|
9.390
|
10.40
|
11.60
|
Cash Flow per Share
2 |
1.440
|
1.370
|
1.750
|
1.390
|
0.6500
|
1.210
|
1.670
|
1.830
|
Capex
1 |
21.7
|
13.3
|
15.5
|
19.7
|
23.1
|
23.9
|
24.8
|
31
|
Capex / Sales
|
3%
|
1.64%
|
1.49%
|
1.95%
|
2.76%
|
2.56%
|
2.32%
|
2.56%
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
40.61
USD Average target price
45.4
USD Spread / Average Target +11.80% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.71% | 6.98B | | +6.56% | 32.91B | | +17.38% | 8.1B | | +20.18% | 5.45B | | -3.97% | 4.13B | | +34.04% | 3.95B | | +17.24% | 3.8B | | +5.47% | 3.4B | | -9.99% | 2.72B | | +8.20% | 2.43B |
Testing & Measuring Equipment
|